The additive effect of latanoprost 0.005
β
Shari E. Strier
π
Article
π
1997
π
Elsevier Science
π
English
β 699 KB
To determine the IOP lowering effect of latanoprost 0.005% when added to patients already on maximum tolerated medical therapy and not at target IOP. Design: Eye Clinic records of glaucoma patients at the Baltimore VAMC who were on maximum tolerated medical therapy and who had latanoprost 0.005% add